Tenax Therapeutics (TENX) Share-based Compensation (2010 - 2026)
Tenax Therapeutics' Share-based Compensation came in at $3.33 million for Q2 2026, down 27.8% from $4.61 million a year earlier but up 17.3% from the prior quarter.
Powered by 
Analysis
Tenax Therapeutics (TENX) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Tenax Therapeutics reported Share-based Compensation of $16.58 million, up 70.3% year-over-year; for FY2025, it was $19.16 million.
- Share-based Compensation carries a five-year compound annual growth rate of 186.1% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $1.13 million in FY2024 (+489.0%) and $191,000 in FY2023.
- The five-year range for quarterly Share-based Compensation is $14,000 (Q3 2024) to $5.62 million (Q3 2025).
- Business Quant data shows TENX's Share-based Compensation at $2.84 million (Q1 2026), $4.79 million (Q4 2025) and $5.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Tenax Therapeutics | 82.92 Mn | -350.75 Mn | - | 2.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.80 Mn |
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | 5.50 Mn |
| Jun 30, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.14 Mn |
| Dec 31, 2024 | 970,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Dec 31, 2023 | 37,162.00 |
| Sep 30, 2023 | 37,012.00 |
| Jun 30, 2023 | 50,283.00 |
| Mar 31, 2023 | 66,543.00 |
| Dec 31, 2022 | 85,628.00 |
| Sep 30, 2022 | 86,586.00 |
| Jun 30, 2022 | 110,031.00 |
| Mar 31, 2022 | 83,069.00 |
| Dec 31, 2021 | 216,580.00 |
| Sep 30, 2021 | 373,259.00 |
API Access
Tenax Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TENX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TENX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TENX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();